Post-treatment Levels of α-Fetoprotein Predict Incidence of Hepatocellular Carcinoma After Interferon Therapy
- 9 December 2013
- journal article
- research article
- Published by Elsevier BV in Clinical Gastroenterology and Hepatology
- Vol. 12 (7), 1186-1195
- https://doi.org/10.1016/j.cgh.2013.11.033
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Determinants of Serum Alpha-Fetoprotein Levels in Hepatitis C–Infected PatientsClinical Gastroenterology and Hepatology, 2012
- Maintenance Peginterferon Therapy and Other Factors Associated With Hepatocellular Carcinoma in Patients With Advanced Hepatitis CGastroenterology, 2011
- Clinical, virologic, histologic, and biochemical outcomes after successful HCV therapy: A 5-year follow-up of 150 patientsHepatology, 2008
- Prolonged-interferon therapy reduces hepatocarcinogenesis in aged-patients with chronic hepatitis CJournal of Medical Virology, 2007
- Risk factors for the development of hepatocellular carcinoma among patients with chronic hepatitis C who achieved a sustained virological response to interferon therapyJournal of Gastroenterology and Hepatology, 2005
- Long‐term follow‐up of sustained responders to interferon therapy, in patients with chronic hepatitis CJournal of Viral Hepatitis, 2000
- Risk factors for hepatocellular carcinoma and its incidence after interferon treatment in patients with chronic hepatitis CHepatology, 1998
- An algorithm for the grading of activity in chronic hepatitis CHepatology, 1996
- Long-term biochemical and virological response to natural interferon-α in patients with chronic hepatitis CDigestive Diseases and Sciences, 1996
- Improvement of liver fibrosis in chronic hepatitis C patients treated with natural interferon alphaJournal of Hepatology, 1995